1. Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., et al. (2007). Revised response criteria for malignant lymphoma. Journal of Clinical Oncology, 25, 579–586.
2. IMV (2006). 2005/06 PET market summary report. IMV Medical Information Division: Des Plaines.
3. Warburg, O., Posener, K., & Negelein, E. (1924). Ueber den Stoffwechsel von Tumoren. Biochemische Zeitschrift, 152, 319–344.
4. Czernin, J., Allen-Auerbach, M., & Schelbert, H. R. (2007). Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. Journal of Nuclear Medicine, 48(Suppl 1), 78S–88S.
5. Israel, O., & Kuten, A. (2007). Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care. Journal of Nuclear Medicine, 48(Suppl 1), 28S–35S.